Table 4.
Excerpt of parameters tested by Kruskal-Wallis analysis
| Comparison of variables grouped by years Group 1: 2009–2011 Group 2: 2012–2014 Group 3: 2015–2017 Group 4: 2018–2020 |
Level of significance |
| Patient gender | 0.467 |
| Patient age | 0.486 |
| Time to diagnosis (months) | 0.473 |
| T-category (TNM 8th edition) | 0.408 |
| BCVA | 0.652 |
| Laterality | 0.084 |
| Risk factors | |
| Immunosuppression | 0.371 |
| Neurodermitis | 0.797 |
| Multiple lesions | 0.453 |
| Therapy | 0.396 |
| Location | |
| Upper eyelid only | 0.976 |
| Lower eyelid only | 0.535 |
| Medial canthal area | 0.107 |
| Lateral canthal area | 0.385 |
| Disease-specific survival (months) | 0.271 |
| Recurrence | 0.491 |
| Nodal metastasis | 0.980 |
| Distant metastasis | 0.361 |
BCVA, best-corrected visual acuity.